PA
CPIX icon

Perceptive Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Perceptive Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$640K Sell
196,978
-144,109
-42% -$555K 0.01% 90
2025
Q4 		$1.36M Buy
+341,087
New +$1.01M 0.02% 107

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors's CPIX Position: Q1 2026 in Review

Perceptive Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 42% in Q1 2026, selling an estimated $555K and leaving 196,978 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #90.

Perceptive Advisors first reported a position in CPIX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.36M in Q4 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Perceptive Advisors held 196,978 shares of Cumberland Pharmaceuticals worth $640K as of Q1 2026.
  • Perceptive Advisors sold 144,109 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $555K.
  • Cumberland Pharmaceuticals made up 0.01% of Perceptive Advisors's portfolio in Q1 2026, its #90 holding.
  • Perceptive Advisors first reported a position in Cumberland Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Perceptive Advisors's Cumberland Pharmaceuticals position peaked at $1.36M in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.